-
4741
Primary splenic anaplastic variant of diffuse large B-cell lymphoma: a case report
Published 2021-05-01“…Abstract Background Primary splenic lymphoma represents a rare entity that constitutes less than 1% of non-Hodgkin lymphomas, and less than 2% of all lymphomas. Diffuse large B-cell lymphoma (DLBCL) is the most common histological subtype of primary splenic lymphomas. …”
Get full text
Article -
4742
Aggressive primary gastric lymphoma (PGL) masquerading as hepatocellular cancer (HCC) in alcoholic cirrhosis
Published 2021-03-01“…Abstract Background The gastrointestinal tract is sa well-known site for extranodal Non-Hodgkin lymphomas, with the stomach is known to be the most common site on lymphoma, primary gastric lymphoma (PGL). …”
Get full text
Article -
4743
Aspartame Safety as a Food Sweetener and Related Health Hazards
Published 2023-08-01“…Epidemiology studies also evidenced associations between daily aspartame intake and a higher predisposition for malignant diseases, like non-Hodgkin lymphomas and multiple myelomas, particularly in males, but an association by chance still could not be excluded. …”
Get full text
Article -
4744
Spectrum of Radiological Manifestations in Lymphoproliferative Malignancies with Unusual Extra Nodal Soft Tissue Involvement
Published 2016-07-01“…Lymphoproliferative malignancies constitute a wide spectrum of haematological malignancies and their prevalence is widely increasing. Non-Hodgkin lymphomas and Hodgkin disease, frequently involve extranodal soft tissue structures in the head and neck, thorax and abdomen. …”
Get full text
Article -
4745
Anaplastic Large Cell Lymphoma with Generalized Skin Lesion in Childhood: Clinical Case
Published 2020-12-01“…Anaplastic large cell lymphoma (ALCL) represents 15% of all non-Hodgkin lymphomas (NHL) in children, and it is characterized by aggressive course and involvement of various organs and systems (including skin) in the pathological process. …”
Get full text
Article -
4746
Translational Applications of Artificial Intelligence and Machine Learning for Diagnostic Pathology in Lymphoid Neoplasms: A Comprehensive and Evolutive Analysis
Published 2021-05-01“…Thematically, current research is focused on the integration of digital image analysis and genomic sequencing in Non-Hodgkin lymphomas, prediction of chemotherapy response and validation of new prognostic models. …”
Get full text
Article -
4747
Novel targeted drugs for follicular and marginal zone lymphoma: a comprehensive review
Published 2023-05-01“…Although mostly incurable, indolent non-Hodgkin lymphomas (iNHL) are chronic diseases with a median overall survival approaching 20 years. …”
Get full text
Article -
4748
Targeting the DNA Damage Response to Increase Anthracycline-Based Chemotherapy Cytotoxicity in T-Cell Lymphoma
Published 2022-03-01“…Mature T-cell lymphomas (MTCLs) represent a heterogeneous group of aggressive non-Hodgkin lymphomas comprising different entities. Anthracycline-based regimens are considered the standard of care in the front-line treatment. …”
Get full text
Article -
4749
Polymorphism of autoimmune encephalitis
Published 2019-06-01“…The first patient was diagnosed with a cross-autoimmune syndrome with a combination of Hodgkins lymphoma and anti-NMDA encephalitis, probably triggered by the reactivation of the EpsteinBarr virus with a fatal outcome. …”
Get full text
Article -
4750
Multifocal Colonic Ulcerations: An Unusual Presentation of Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma
Published 2021-04-01“…Introduction: Mucosa-associated lymphoid tissue (MALT) lymphoma is relatively uncommon and accounts for only 5% of all non-Hodgkin lymphomas. The most common site of extranodal involvement is the gastrointestinal (GI) tract, with most cases affecting the stomach (up to 75% of all GI MALT lymphomas). …”
Get full text
Article -
4751
Recurrent Mantle Cell Lymphoma Presenting as Gastrointestinal Bleeding
Published 2018-08-01“…Mantle cell lymphoma is a rare and aggressive subtype of B-cell non-Hodgkin lymphomas. Mantle cell lymphoma frequently involves extranodal sites, and gastrointestinal tract is involved microscopically and macroscopically in more than 80% of cases. …”
Get full text
Article -
4752
Targeted alpha anticancer therapies: update and future prospects
Published 2014-11-01“…Clinical trial outcomes are reviewed for neuroendocrine tumors, leukemia, glioma, melanoma, non-Hodgkins lymphoma, and prostate bone metastases. Recommendations and future directions are proposed.Keywords: biodosimetry, microdosimetry, mutagenesis, PAI2, bevacizumab, C595, J591, tumors, cancer, metastases…”
Get full text
Article -
4753
Lennert′s lymphoma: Clinicopathological profile of five cases
Published 2013-01-01“…Conclusions: Lennert′s lymphoma constituted 0.11% of all non-Hodgkin lymphomas (NHLs) in our institution. Differentiation from classical Hodgkin′s lymphoma is sometimes difficult by morphology and immunohistochemistry alone and TCR gene rearrangement was extremely useful in diagnosis.…”
Get full text
Article -
4754
Central Nervous System Progression/Relapse in Mature T- and NK-Cell Lymphomas
Published 2023-02-01“…Non-Hodgkin lymphomas (NHL) are cancers of mature B-, T-, and NK-cells which display marked biological heterogeneity between different subtypes. …”
Get full text
Article -
4755
Epstein-Barr Virus (EBV)-Related Lymphoproliferative Disorders in Ataxia Telangiectasia: Does ATM Regulate EBV Life Cycle?
Published 2019-01-01“…However, immunocompromised patients may be unable to control EBV infection and are at increased risk of EBV-related malignancies, such as diffuse large B-cell lymphomas or Hodgkin's lymphomas. Ataxia telangiectasia (AT) is a primary immunodeficiency caused by mutations in the ATM gene and associated with an increased incidence of cancers, particularly EBV-associated lymphomas. …”
Get full text
Article -
4756
Inflammasomes—New Contributors to Blood Diseases
Published 2022-07-01“…The NLRP3 inflammasome correlated with the pathogenesis of non-Hodgkin lymphomas, multiple myeloma, acute myeloid leukemia, lymphoid leukemias, myelodysplastic neoplasms, graft-versus-host-disease, and sickle cell anemia. …”
Get full text
Article -
4757
CAR-T Cell Therapy in Diffuse Large B Cell Lymphoma: Hype and Hope
Published 2019-04-01“…Patients with non-Hodgkin lymphomas (NHLs) resistant to standard therapies have a dismal prognosis. …”
Get full text
Article -
4758
Serologic detection of diffuse large B-cell lymphoma-associated antigens.
Published 2004“…Diffuse large B-cell lymphoma (DLBCL) accounts for 30-40% of all adult non-Hodgkin's lymphomas, yet the understanding of its underlying genetic abnormalities remains poor. …”
Journal article -
4759
Applying population mechanistic modelling to find determinants of CAR-T dynamics in month-one lymphoma patients
Published 2024“…Chimeric Antigen Receptor (CAR) T-cells have been utilised for the treatment of several malignancies, including Non-Hodgkin Lymphomas (NHL). A myriad of product- and patient-specific factors determine the extent of patient response, and determining which are most impactful requires analysis of clinical data. …”
Journal article -
4760
Paternal occupational contact level and childhood leukaemia in rural Scotland: a case-control study.
Published 2001“…In a national Scottish study of 809 cases of leukaemia and non-Hodgkins lymphoma diagnosed in 1950-89 among children aged 0-4 years who were born in Scotland, together with 2363 matched population controls, we investigated one aspect of the infective hypothesis. …”
Journal article